| NASH limits anti-tumour surveillance in immunotherapy-treated HCC D Pfister, NG Núñez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ... Nature 592 (7854), 450-456, 2021 | 785 | 2021 |
| Impaired endothelial autophagy promotes liver fibrosis by aggravating the oxidative stress response during acute liver injury M Ruart, L Chavarria, G Campreciós, N Suárez-Herrera, C Montironi, ... Journal of Hepatology 70 (3), 458-469, 2019 | 219 | 2019 |
| Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma R Montal, D Sia, C Montironi, WQ Leow, R Esteban-Fabró, R Pinyol, ... Journal of hepatology 73 (2), 315-327, 2020 | 198 | 2020 |
| Portal pressure and liver stiffness measurements in the prediction of fibrosis regression after sustained virological response in recurrent hepatitis C E Mauro, G Crespo, C Montironi, MC Londoño, V Hernández‐Gea, P Ruiz, ... Hepatology 67 (5), 1683-1694, 2018 | 166 | 2018 |
| An immune gene expression signature associated with development of human hepatocellular carcinoma identifies mice that respond to chemopreventive agents A Moeini, S Torrecilla, V Tovar, C Montironi, C Andreu-Oller, J Peix, ... Gastroenterology 157 (5), 1383-1397. e11, 2019 | 73 | 2019 |
| Molecular portrait of high alpha-fetoprotein in hepatocellular carcinoma: implications for biomarker-driven clinical trials R Montal, C Andreu-Oller, L Bassaganyas, R Esteban-Fabró, S Moran, ... British journal of cancer 121 (4), 340-343, 2019 | 71 | 2019 |
| Liver CPT1A gene therapy reduces diet‐induced hepatic steatosis in mice and highlights potential lipid biomarkers for human NAFLD M Weber, P Mera, J Casas, J Salvador, A Rodríguez, S Alonso, ... Federation of American Societies for Experimental Biology, 2020 | 68 | 2020 |
| Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer J Codony-Servat, M Cuatrecasas, E Asensio, C Montironi, ... British journal of cancer 117 (12), 1777-1786, 2017 | 65 | 2017 |
| Validation of whole-slide imaging in the primary diagnosis of liver biopsies in a university hospital A Saco, A Diaz, M Hernandez, D Martinez, C Montironi, P Castillo, ... Digestive and Liver Disease 49 (11), 1240-1246, 2017 | 27 | 2017 |
| New drugs effective in the systemic treatment of hepatocellular carcinoma C Montironi, R Montal, JM Llovet Clinical liver disease 14 (2), 56-61, 2019 | 26 | 2019 |
| Endoscopic tattooing of early colon carcinoma enhances detection of lymph nodes most prone to harbor tumor burden I Aldecoa, C Montironi, N Planell, M Pellise, G Fernandez-Esparrach, ... Surgical Endoscopy 31, 723-733, 2017 | 22 | 2017 |
| Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma N Rakislova, C Montironi, I Aldecoa, E Fernandez, JA Bombi, M Jimeno, ... Journal of Translational Medicine 15, 1-10, 2017 | 21 | 2017 |
| Hepatic epithelioid hemangioendothelioma: an international multicenter study M Sanduzzi-Zamparelli, J Rimola, C Montironi, V Nunes, VAF Alves, ... Digestive and Liver Disease 52 (9), 1041-1046, 2020 | 19 | 2020 |
| Infiltrative xanthogranulomatous cholecystitis mimicking aggressive gallbladder carcinoma: A diagnostic and therapeutic dilemma LS Nacif, AJ Hessheimer, SR Gómez, C Montironi, C Fondevila World journal of gastroenterology 23 (48), 8671, 2017 | 19 | 2017 |
| Immunomodulatory effects of lenvatinib plus anti-PD1 in mice and rationale for patient enrichment in hepatocellular carcinoma. L Torrens, C Montironi, M Puigvehí, A Mesropian, J Leslie, PK Haber, ... Hepatology, 2021, vol. 74, num. 5, p. 2652-2669, 2021 | 15 | 2021 |
| Oropharyngeal syphilis: imaging and pathologic findings in two patients E Ripoll, C Montironi, L Alós, T Pujol, J Berenguer, L Oleaga Head and neck pathology 11, 399-403, 2017 | 10 | 2017 |
| Viral eradication and fibrosis resolution in post–liver transplant cholestatic hepatitis C virus E Mauro, G Crespo, C Montironi, MC Londoño, A Díaz, X Forns, ... Liver Transplantation 24 (5), 703-707, 2018 | 6 | 2018 |
| Cabozantinib enhances the efficacy and immune modulatory activity of anti-PD1 therapy in a syngeneic mouse model of hepatocellular carcinoma R Esteban-Fabró, CE Willoughby, M Piqué-Gili, J Peix, C Montironi, ... Journal of Hepatology 73, S40, 2020 | 5 | 2020 |
| Neumonía organizada con desenlace fatal tras quimioterapia adyuvante con FOLFOX A Vargas, C Montironi, E Buxó Arch. bronconeumol.(Ed. impr.), 610-610, 2015 | 2 | 2015 |
| Molecular Classification and Potential Therapeutic Targets in Extrahepatic Cholangiocarcinoma R Montal, WQ Leow, C Montironi, L Bassaganyas, A Moeini, D Sia, ... Hepatology 68, 18A-19A, 2018 | 1 | 2018 |
